NuCana PLC Sponsored ADR (NCNA) vs Orgenesis Inc. (ORGS)

NuCana PLC Sponsored ADR and Orgenesis Inc. are both Biotechnology companies. NuCana PLC Sponsored ADR and Orgenesis Inc. are of similar size ($5.7M and $5.7M). NuCana PLC Sponsored ADR has the higher net margin (0.00% vs −4,653.6%) and the lower return on invested capital (−1,130.2% vs 0.00%). Across the 13 metrics below, NuCana PLC Sponsored ADR leads on 7 and Orgenesis Inc. on 6.

Valuation

Metric NCNA ORGS Biotechnology median
P/E n/m n/m 7.88
P/S n/m 2.03 11.47
P/B 0.00 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 1.45 n/m 0.74
EV/Sales n/m 17.50 10.73
Earnings yield (175,037.66%) (2,302.00%) (28.84%)
Free cash flow yield (131,687.13%) (823.55%) (23.03%)

Profitability

Metric NCNA ORGS Biotechnology median
Gross margin 0.00% (86.28%) 65.16%
Operating margin 0.00% (3,842.32%) 0.00%
Net margin 0.00% (4,653.62%) 0.00%
Free cash flow margin 0.00% (1,675.27%) 0.00%
Return on equity (68.70%) 164.62% (57.72%)
Return on assets (45.24%) (605.73%) (49.22%)
Return on invested capital (1,130.23%) 0.00% 0.00%

Growth

Metric NCNA ORGS Biotechnology median
Revenue growth (TTM) — 95.28% 5.64%
EPS growth (last fiscal year) 98.96% 40.10% —
Revenue growth, 5-year CAGR — (23.30%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NCNA ORGS Biotechnology median
Debt to equity 0.00 (0.44) 0.00
Current ratio 4.73 0.03 4.73
Net debt to EBITDA 1.23 (0.42) 0.96

Dividend

Metric NCNA ORGS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NCNA ORGS Biotechnology median
Market cap 5.69m 5.68m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack